Alendronate Sodium Tablets


Indications and Reactions:

Role Indications Reactions
Primary
Osteoporosis 95.8%
Osteoporosis 2.1%
Product Used For Unknown Indication 0.5%
Bone Density Decreased 0.3%
Drug Use For Unknown Indication 0.3%
Hiv Infection 0.3%
Hormone Replacement Therapy 0.3%
Oseoporosis 0.3%
Osteoporisis 0.3%
Pain 56.0%
Stress Fracture 11.7%
Quality Of Life Decreased 10.5%
Multiple Injuries 8.2%
Unevaluable Event 7.0%
Spinal Fracture 1.2%
Tibia Fracture 1.2%
Physical Disability 0.8%
Femur Fracture 0.4%
Fracture Nonunion 0.4%
Laryngeal Ulceration 0.4%
Pathological Fracture 0.4%
Pelvic Fracture 0.4%
Pubis Fracture 0.4%
Skeletal Injury 0.4%
Toxicity To Various Agents 0.4%
Upper Limb Fracture 0.4%
Secondary
Osteoporosis 95.8%
Osteoporosis 2.6%
Product Used For Unknown Indication 0.6%
Drug Use For Unknown Indication 0.3%
Oseoporosis 0.3%
Osteoporisis 0.3%
Pain 56.0%
Stress Fracture 12.4%
Multiple Injuries 9.8%
Quality Of Life Decreased 8.8%
Unevaluable Event 8.3%
Physical Disability 1.0%
Spinal Fracture 1.0%
Tibia Fracture 1.0%
Femur Fracture 0.5%
Pelvic Fracture 0.5%
Upper Limb Fracture 0.5%
Concomitant
Osteoporosis 100.0%
Skeletal Injury 100.0%

Drug Data